Search results
How the City was strangled by red tape
The Telegraph via Yahoo Finance· 4 days agoAddressing a room of people who collectively controlled billions of pounds last autumn, Julia Hoggett said “every mother in Cumbria” should care about...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks· 5 days agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face the FDA's partial clinical hold following the death of two patients.
Anti-Israel student protests putting ‘handbrake’ on corporate diversity spending, says MindGym
The Telegraph via Yahoo Finance· 6 days agoAnti-Israel student protests on university campuses and Ron DeSantis’s so-called war on woke have...
ASCO 2024: How to Best Use New Breast Cancer Data
Medscape· 4 days agoKevin Kalinsky and Sara Hurvitz discuss the results of awaited data in the breast cancer space presented at the 2024 ASCO Annual Meeting.
How germ granules promote germ cell fate - Nature Reviews Genetics
Nature· 5 days agoIn this Review, Pamula and Lehmann describe how distinct membraneless germ granules organize the germ cell cytoplasm at different stages of the germline life cycle to determine germ cell identity ...
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
Zacks· 7 days agoMaking matters worse, income generated using tried-and-true retirement planning approaches may not cover expenses these days. In the past, investors going into retirement could invest in bonds ...
FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer - AstraZeneca (NASDAQ:AZN)
Benzinga· 6 days agoAstraZeneca plc’s AZN cancer drug, Imfinzi (durvalumab), in conjunction with standard chemotherapy,...
Gateway - Quartz
Quartz· 5 days agoThe millennial-targeted Hims & Hers this week joined other telehealth platforms in offering customers a cheaper, compounded version of semaglutide, the active ingredient in popular weight loss ...
Major drug companies cap asthma medication costs at $35 per month
KSBW Salinas· 2 days agoMajor pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at...
Baird lifts Mirum Pharmaceuticals shares target on study results By Investing.com
Investing.com· 6 days agoOn Monday, Baird increased its price target on Mirum Pharmaceuticals (NASDAQ:MIRM) shares to $39...
